AJOONI BIOTECH LIMITED vs MARICO LIMITED
A side-by-side comparison of AJOONI BIOTECH LIMITED (AJOONI) and MARICO LIMITED (MARICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, MARICO LIMITED leads AJOONI vs MARICO on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth20
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
MARICO takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
AJOONI takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
MARICO takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.72 times its book value", "Company is expected to give good quarter", "Debtor days have improved from 48.8 to 35.7 days.", "Company's median sales growth is 35.1% of last 10 years", "Company's working capital requirements have reduced from 129 days to 93.5 days"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 30.5%", "Company has a low return on equity of 4.99% over last 3 years."]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
- − ["Stock is trading at 25.6 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.